Patent: 10,064,936
✉ Email this page to a colleague
Summary for Patent: 10,064,936
| Title: | Mixed allergen compositions and methods for using the same |
| Abstract: | Mixed allergen compositions of two or more different allergens are provided. In some instances, the mixed allergen compositions include: a nut allergen; an animal allergen; and at least one of: a non-nut plant allergen; a biotic agent; and a vitamin. Also provided are methods of administering the mixed allergen compositions to a subject. The mixed allergen compositions find use in a variety of applications, including health maintenance, immune balance, gut balance, immune support, health improvement and therapeutic applications. |
| Inventor(s): | Nadeau; Kari C. (Los Altos Hills, CA) |
| Assignee: | The Board of Trustees of the Leland Stanford Junior University (Stanford, CA) |
| Application Number: | 15/048,609 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,064,936
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | PALFORZIA | peanut (arachis hypogaea) allergen powder-dnfp | Powder | 125696 | January 31, 2020 | ⤷ Start Trial | 2036-02-19 |
| Novo Nordisk Inc. | XULTOPHY 100/3.6 | insulin degludec and liraglutide | Injection | 208583 | November 21, 2016 | ⤷ Start Trial | 2036-02-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,064,936
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016134291 | ⤷ Start Trial |
| United States of America | 10143742 | ⤷ Start Trial |
| United States of America | 10149904 | ⤷ Start Trial |
| United States of America | 10166286 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
